- Global Pharma News & Resources

The Worldwide Opioids Industry is Expected to Reach $6 Billion by 2030 -

DUBLIN--(BUSINESS WIRE)--The "Opioids Market by Product Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to's offering.

The global opioids market was valued at $4,412.48 million in 2020, and is projected to reach $6,060.17 million by 2030, registering a CAGR of 3.2% from 2021 to 2030.

Opioids are pain relievers because they include substances that relax muscles and alleviate pain and stress. Prescription opioids are primarily used to treat moderate to severe pain, while some opioids can be used to alleviate coughing and diarrhea. Hydrocodone, oxycodone, codeine, fentanyl, methadone, morphine, and other pharmaceutical opioids are among them. Opioids are the most commonly prescribed pain relievers for people suffering from moderate to severe chronic pain. These analgesics are used to treat severe continuous pain in individuals with terminal conditions and to manage pain in cancer patients.

The growth of the global opioids market is driven by alarming increase in incidence of orthopedic diseases & chronic pain. Furthermore, rise in disposable income and surge in geriatric population are expected to propel the growth of the global opioids market. However, emergence and legalization of cannabis as an alternative to opioids impede the growth of the market. On the contrary, increase in consumption of opioids analgesic for pain management in developing countries is anticipated to create lucrative opportunities for market expansion in the near future.

The opioids market is segmented on the basis of type of product, application, and region. According to type of product, the market is classified into codeine, fentanyl, oxycodone, methadone, morphine, hydrocodone, and others. On the basis of application, the market is divided into pain management, cough treatment, and diarrhea treatment. The pain management segment is further divided into neuropathic pain, migraine, back pain, osteoarthritis pain, and cancer pain. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • The study provides an in-depth analysis of the global opioids market and current & future trends to elucidate the imminent investment pockets
  • Information about key drivers, restrains, and opportunities and their impact analysis on the market size is provided
  • Porter's five forces analysis illustrates the potency of buyers and suppliers operating in the industry
  • The quantitative analysis of the global market from 2021 to 2030 is provided to determine the market potential

Market Segments

By Product

  • Codeine
  • Fentanyl
  • Oxycodone
  • Methadone
  • Morphine
  • Hydrocodone
  • Others

By Applications

  • Pain management
  • Cough treatment
  • Diarrhea treatment

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Players

  • AstraZeneca PLC
  • Purdue Pharma LP
  • Johnson and Johnson Inc
  • Sanofi SA
  • Mallinckrodt Pharmaceuticals
  • Endo Pharmaceuticals Inc
  • Pfizer, Inc
  • Sun Pharmaceuticals
  • Teva Pharmaceuticals
  • C.H Boehringer Sohn

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 04-May-2022